Supreme Court to weigh FDA’s refusal to approve flavored vapes

Supreme Court to weigh FDA’s refusal to approve flavored vapes


Birds fly outside the U.S. Supreme Court on the day justices issue orders in pending appeals in Washington, U.S., June 24, 2024. 

Nathan Howard | Reuters

WASHINGTON —The Supreme Court on Tuesday agreed to consider whether the Food and Drug Administration acted unlawfully in refusing to approve flavored e-cigarettes that are often used by teens.

The case marks a test of the FDA’s role in approving new nicotine products at a time when new ones are proliferating.

E-cigarette makers have brought court cases around the country challenging the FDA’s decisions.

The FDA won most of them, but appealed to the Supreme Court after the 5th U.S. Circuit Court of Appeals in January ruled in favor of two vape companies seeking to have their products approved. The appeals court concluded that the FDA had failed to correctly assess the companies’ requests in violation of a federal law called the Administrative Procedure Act.

That case was brought by Triton Distribution, which makes e-liquids for vape pens in such flavors as “Signature Series Mom’s Pistachio” and “Suicide Bunny Mother’s Milk and Cookies,” and Vapestasia, which has sought approval for flavors including “Iced Pineapple Express” and “Killer Kustard Bluebery.”

Three other appeals brought by vape companies that lost in lower courts are also pending at the high court.

The FDA has consistently declined to approve flavored vapes, saying they may be a health risk because they may encourage young people to use tobacco, although they remain widely available. The companies say the FDA got it wrong, arguing that their products can be used to help people stop smoking.

The FDA has concluded that the potential benefits to helping adult smokers quit do not outweigh the potential health risks to young people.

Meanwhile, there has been a growth in teens using other products containing nicotine.

The FDA recently approved menthol-flavored e-cigarettes for the first time. It has approved other e-cigarette products as well.

Amid the debate on the potential health dangers of vaping, the FDA this month also rescinded its ban on Juul selling its vape products.



Source

Healthy Returns: 2026 will be the year of obesity pills from Novo Nordisk, Eli Lilly
Health

Healthy Returns: 2026 will be the year of obesity pills from Novo Nordisk, Eli Lilly

Daniel Grill | Tetra Images | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. GLP-1 pills for obesity are closer than ever.  2026 is likely the year that two new oral weight loss […]

Read More
Pfizer’s modest 2026 outlook shows its big investments will take time to pay off
Health

Pfizer’s modest 2026 outlook shows its big investments will take time to pay off

Smith Collection | Archive Photos | Getty Images Pfizer on Tuesday forecast modest 2026 guidance as it looks to longer-term investments in its pipeline to counter waning Covid product sales and declines from older drugs. Those hurdles aren’t surprising or new for Pfizer, which has seen a dramatic decline in Covid vaccine and antiviral sales […]

Read More
Trump says he’s ‘strongly’ considering reclassifying pot via executive order
Health

Trump says he’s ‘strongly’ considering reclassifying pot via executive order

Bill Schmitt Jr. (C) joins cannabis reform protesters outside the White House to call on U.S. President Joe Biden “to take action on cannabis clemency before the November general election” October 24, 2022 in Washington, DC. Win Mcnamee | Getty Images Pot stocks failed to light up for a second day on Monday even after […]

Read More